MENS

As competition intensifies across therapeutic categories, companies are increasingly prioritizing efficient clinical execution and strategic expansion of trial infrastructure. Site activation, patient recruitment, and global trial coordination have become key operational focus areas, particularly for studies approaching completion. These efforts are essential in maintaining timelines and supporting regulatory engagement pathways. Atrium Therapeutics Inc (RNA) Atrium … Read more